Ask AI
ARIA Training Module

CE / CME

Spot the Signal: Global Radiology Training for ARIA Detection in Alzheimer’s Care

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

European Learners: 1.00 EBAC® CE Credit

Released: April 16, 2026

Expiration: April 15, 2027

Activity

Progress
1 2 3
Course Completed

Introduction

In this module, Tammie L. Benzinger, MD, PhD, and Karl-Olof Lövblad, MD, discuss detection of amyloid-related imaging abnormalities (ARIA) and other imaging findings frequently encountered when evaluating patients with Alzheimer’s disease (AD) treated with amyloid-targeted therapy (ATT).

The key points discussed in this module are illustrated with thumbnails from the accompanying downloadable PowerPoint slideset, which can be found here or downloaded by clicking on any of the slide thumbnails in the module alongside the expert commentary.

Please note that Decera Clinical Education plans to measure the educational impact of this activity. Some questions will be asked twice: once at the relevant place in the content, and once again at the end of the module. Your responses will be aggregated for analysis, and your individual responses will not be shared. Thank you in advance for helping us assess the impact of this education.

Before continuing with this educational activity, please take a moment to answer the following questions.

How many patient MRIs do you assess related to amyloid-targeting therapy initiation or monitoring in a typical month?

How confident are you in your ability to assess patient MRIs related to amyloid-targeting therapy initiation or monitoring?

For those who practice in academic or community settings, please indicate your practice setting: